Fox Run Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,219
| Closed | -$296K | – | 1004 |
|
|
2026
Q1 | $296K | Buy |
+4,219
| New | +$325K | 0.05% | 624 |
|
|
2024
Q3 | – | Sell |
-4,407
| Closed | -$260K | – | 856 |
|
|
2024
Q2 | $260K | Buy |
4,407
+638
| +17% | +$39.9K | 0.05% | 587 |
|
|
2024
Q1 | $301K | Sell |
3,769
-10,294
| -73% | -$786K | 0.06% | 535 |
|
|
2023
Q4 | $1.11M | Buy |
14,063
+987
| +8% | +$70.2K | 0.28% | 61 |
|
|
2023
Q3 | $913K | Buy |
+13,076
| New | +$927K | 0.27% | 94 |
|
|
2023
Q2 | – | Sell |
-21,318
| Closed | -$1.58M | – | 747 |
|
|
2023
Q1 | $1.58M | Buy |
+21,318
| New | +$1.79M | 0.52% | 10 |
|
|
2022
Q4 | – | Sell |
-9,600
| Closed | -$916K | – | 674 |
|
|
2022
Q3 | $916K | Buy |
+9,600
| New | +$950K | 0.36% | 31 |
|
|
2022
Q1 | – | Sell |
-9,139
| Closed | -$943K | – | 536 |
|
|
2021
Q4 | $943K | Buy |
+9,139
| New | +$845K | 0.56% | 11 |
|
|
2021
Q3 | – | Sell |
-4,118
| Closed | -$344K | – | 494 |
|
|
2021
Q2 | $344K | Buy |
4,118
+810
| +24% | +$66.3K | 0.31% | 129 |
|
|
2021
Q1 | $249K | Buy |
+3,308
| New | +$241K | 0.45% | 115 |
|
|
2020
Q3 | – | Sell |
-6,559
| Closed | -$426K | – | 201 |
|
|
2020
Q2 | $426K | Buy |
6,559
+2,000
| +44% | +$126K | 0.56% | 30 |
|
|
2020
Q1 | $270K | Buy |
+4,559
| New | +$304K | 0.64% | 36 |
|
|
2019
Q3 | – | Sell |
-5,864
| Closed | -$320K | – | 401 |
|
|
2019
Q2 | $320K | Buy |
5,864
+358
| +7% | +$19.3K | 0.21% | 201 |
|
|
2019
Q1 | $297K | Buy |
5,506
+1,680
| +44% | +$104K | 0.17% | 273 |
|
|
2018
Q4 | $251K | Sell |
3,826
-4,913
| -56% | -$367K | 0.13% | 328 |
|
|
2018
Q3 | $688K | Buy |
+8,739
| New | +$625K | 0.3% | 76 |
|
|
2018
Q2 | – | Sell |
-20,076
| Closed | -$1.25M | – | 712 |
|
|
2018
Q1 | $1.25M | Buy |
20,076
+12,373
| +161% | +$888K | 0.3% | 37 |
|
|
2017
Q4 | $558K | Buy |
+7,703
| New | +$560K | 0.16% | 253 |
|
|
2017
Q3 | – | Sell |
-6,300
| Closed | -$507K | – | 709 |
|
|
2017
Q2 | $507K | Buy |
6,300
+1,800
| +40% | +$142K | 0.18% | 217 |
|
|
2017
Q1 | $353K | Sell |
4,500
-500
| -10% | -$39.9K | 0.14% | 308 |
|
|
2016
Q4 | $395K | Sell |
5,000
-1,000
| -17% | -$80.9K | 0.21% | 204 |
|
|
2016
Q3 | $534K | Buy |
6,000
+3,100
| +107% | +$293K | 0.31% | 80 |
|
|
2016
Q2 | $278K | Buy |
+2,900
| New | +$289K | 0.14% | 322 |
|
Other funds holding CVS
Fox Run Management's CVS Position: Q2 2026 in Review
Fox Run Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 4,219 shares — an estimated $296K sold.
Fox Run Management first reported a position in CVS in Q2 2016 and held it in 23 quarters. The position peaked at $1.58M in Q1 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Fox Run Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
- Fox Run Management sold 4,219 CVS Health shares in Q2 2026, an estimated $296K.
- Fox Run Management first reported a position in CVS Health in Q2 2016 and held it in 23 quarters.
- Fox Run Management's CVS Health position peaked at $1.58M in Q1 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.